Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Neurobiology of Aging|December 13, 2016
Gray matter network differences between behavioral variant frontotemporal dementia and Alzheimer's diseaseE G B Vijverberg, B M Tijms, J Dopp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2012
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progressionC E Teunissen, M Sombekke, L van Winsen, et al.
Journal of Neurology|April 6, 2024
NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel diseaseAnnelise E Wilms, I de Boer, N Pelzer, et al.
Alzheimer'S Research & Therapy|April 19, 2020
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodiesM van de Beek, R Babapour Mofrad, I van Steenoven, et al.
Journal of Neurology|November 4, 2025
VGF AQEE- and GGEE-peptides differentiate between dementia typesB Noli, B Muqaku, M Gouda, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosisM H J Vogt, C E Teunissen, E Iacobaeus, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 16, 2017
Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatmentCyra E Leurs, Petar Podlesniy, Ramon Trullas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2021
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patientsZygj van Lierop, A A Toorop, Eme Coerver, et al.
Neurobiology of Aging|December 21, 2002
Serum cholesterol, precursors and metabolites and cognitive performance in an aging populationC E Teunissen, J De Vente, K von Bergmann, et al.
Pageof 6